Hikma Pharmaceuticals Plc Shares Outstanding 2016-2018 | HKMPF

Hikma Pharmaceuticals Plc shares outstanding history from 2016 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Hikma Pharmaceuticals Plc shares outstanding for the quarter ending December 31, 2018 were M, a NAN% increase year-over-year.
  • Hikma Pharmaceuticals Plc 2018 shares outstanding were 0.242B, a 0.41% increase from 2017.
  • Hikma Pharmaceuticals Plc 2017 shares outstanding were 0.241B, a 2.99% increase from 2016.
  • Hikma Pharmaceuticals Plc 2016 shares outstanding were 0.234B, a 16.42% increase from 2015.
Hikma Pharmaceuticals Plc Annual Shares Outstanding
(Millions of Shares)
2018 242
2017 241
2016 234
2015 201
Hikma Pharmaceuticals Plc Quarterly Shares Outstanding
(Millions of Shares)
2018-12-31
2018-06-30
2017-12-31
2017-06-30
2016-12-31
2015-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $6.906B $2.207B
Hikma Pharmaceuticals PLC develops, manufactures and markets pharmaceutical products. Its brand portfolio includes branded, injectables and generic. Branded segment offers dosage forms and strengths in the anti-infective, cardiovascular, diabetes, central nervous system, oncology and respiratory. Injectables segment offers dosage for CNS, controlled substances, anti-infective, cardiovascular and oncology in form of liquid, semi-liquid and powdered form. Generics segment offers dosage for therapeutic including analgesic, anti-infective, anti-inflammatory, cardiovascular, CNS, respiratory and hormonal. Hikma Pharmaceuticals PLC is based in London, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $59.894B 34.65
Takeda Pharmaceutical (TAK) Japan $49.971B 8.76
Astellas Pharma (ALPMY) Japan $28.823B 14.40
Eisai (ESALY) Japan $20.591B 38.36
UCB SA (UCBJF) Belgium $15.687B 0.00
Grifols, S.A (GRFS) Spain $13.751B 17.09
Merck (MKGAF) Germany $12.892B 16.91
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $8.704B 241.82
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.874B 0.00
Catalent (CTLT) United States $7.719B 31.76
Ionis Pharmaceuticals (IONS) United States $6.971B 21.13
Jazz Pharmaceuticals (JAZZ) Ireland $5.906B 7.20
Orion OYJ (ORINY) Finland $5.269B 23.61
IPSEN SA ADR (IPSEY) France $4.719B 0.00
STADA ARZNEIMI (STDAF) Germany $4.685B 0.00
Forty Seven (FTSV) United States $4.599B 0.00
United Therapeutics (UTHR) United States $4.172B 0.00
Evotec AG (EVTCY) Germany $3.769B 60.79
Hypermarcas (HYPMY) Brazil $3.681B 11.20
Nektar Therapeutics (NKTR) United States $3.123B 0.00
FibroGen (FGEN) United States $3.003B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.988B 55.45
PTC Therapeutics (PTCT) United States $2.680B 0.00
ChemoCentryx (CCXI) United States $2.626B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.366B 9.57
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.628B 0.00
Xencor (XNCR) United States $1.607B 65.63
Ironwood Pharmaceuticals (IRWD) United States $1.525B 18.54
Sage Therapeutics (SAGE) United States $1.507B 0.00
USANA Health Sciences (USNA) United States $1.495B 15.70
Theravance Biopharma (TBPH) Cayman Islands $1.421B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.372B 37.51
Corcept Therapeutics (CORT) United States $1.261B 14.10
Heron Therapeutics (HRTX) United States $1.225B 0.00
Karyopharm Therapeutics (KPTI) United States $1.218B 0.00
Zogenix (ZGNX) United States $1.081B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.015B 31.43
Esperion Therapeutics (ESPR) United States $0.909B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.871B 12.13
Akebia Therapeutics (AKBA) United States $0.870B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.802B 0.00
Endo (ENDP) Ireland $0.730B 1.35
Tilray (TLRY) Canada $0.663B 0.00
Molecular Templates (MTEM) United States $0.637B 0.00
Translate Bio (TBIO) United States $0.617B 0.00
Collegium Pharmaceutical (COLL) United States $0.604B 0.00
ImmunoGen (IMGN) United States $0.591B 0.00
Aerie Pharmaceuticals (AERI) United States $0.590B 0.00
Radius Health (RDUS) United States $0.565B 0.00
Portola Pharmaceuticals (PTLA) United States $0.517B 0.00
Siga Technologies (SIGA) United States $0.418B 0.00
Indivior (INVVY) United States $0.401B 2.38
BioSpecifics Technologies Corp (BSTC) United States $0.401B 16.45
Innate Pharma SA (IPHYF) France $0.385B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.385B 12.83
Calithera Biosciences (CALA) United States $0.371B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.370B 0.00
Ardelyx (ARDX) United States $0.353B 0.00
Organogenesis Holdings (ORGO) United States $0.327B 0.00
Trillium Therapeutics (TRIL) Canada $0.324B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.320B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.310B 0.00
DURECT (DRRX) United States $0.300B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.299B 0.00
Flexion Therapeutics (FLXN) United States $0.295B 0.00
Lannett Co Inc (LCI) United States $0.289B 4.65
Harpoon Therapeutics (HARP) United States $0.287B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.276B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.272B 0.00
Ocular Therapeutix (OCUL) United States $0.264B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.262B 0.00
TherapeuticsMD (TXMD) United States $0.243B 0.00
Concert Pharmaceuticals (CNCE) United States $0.242B 0.00
Rafael Holdings (RFL) United States $0.209B 0.00
OptiNose (OPTN) United States $0.182B 0.00
CASI Pharmaceuticals (CASI) United States $0.182B 0.00
Recro Pharma (REPH) United States $0.178B 0.00
PROFOUND MEDICL (PROF) Canada $0.172B 0.00
MEI Pharma (MEIP) United States $0.160B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.154B 0.00
Jounce Therapeutics (JNCE) United States $0.154B 2.77
Nature's Sunshine Products (NATR) United States $0.148B 18.58
KalVista Pharmaceuticals (KALV) United States $0.138B 0.00
Taiwan Liposome (TLC) Taiwan $0.137B 0.00
Redhill Biopharma (RDHL) Israel $0.134B 0.00
VAXART, INC (VXRT) United States $0.119B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.107B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.103B 0.00
CannTrust Holdings (CTST) Canada $0.090B 0.00
SCYNEXIS (SCYX) United States $0.084B 0.00
Champions Oncology (CSBR) United States $0.083B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.083B 0.00
IMV INC (IMV) Canada $0.081B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.079B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.076B 0.00
Hemispherx BioPharma (AIM) United States $0.072B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.072B 0.00
Biomerica (BMRA) United States $0.072B 0.00
CTI BioPharma (CTIC) United States $0.070B 0.00
Aquestive Therapeutics (AQST) United States $0.069B 0.00
Xeris Pharmaceuticals (XERS) United States $0.064B 0.00
CV Sciences (CVSI) United States $0.064B 0.00
Otonomy (OTIC) United States $0.060B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.055B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.055B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.054B 16.95
Nivalis Therapeutics (ALPN) United States $0.052B 0.00
PharmAthene (ALT) United States $0.051B 0.00
Infinity Pharmaceuticals (INFI) United States $0.051B 0.00
Onconova Therapeutics (ONTX) United States $0.049B 0.00
Aclaris Therapeutics (ACRS) United States $0.047B 0.00
Natural Alternatives (NAII) United States $0.045B 20.34
Sundial Growers (SNDL) Canada $0.043B 0.00
GTx (ONCT) United States $0.043B 0.00
MediWound (MDWD) Israel $0.042B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 131.71
Neos Therapeutics (NEOS) United States $0.038B 0.00
Forward Pharma (FWP) Denmark $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
PolarityTE (PTE) United States $0.033B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.033B 0.00
IsoRay (ISR) United States $0.031B 0.00
AgeX Therapeutics (AGE) United States $0.031B 0.00
Heat Biologics (HTBX) United States $0.028B 0.00
ElectroCore (ECOR) United States $0.026B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.025B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.025B 0.00
Cardiome Pharma (CORV) Canada $0.024B 0.00
Jaguar Animal Health (JAGX) United States $0.024B 0.00
Mannatechorporated (MTEX) United States $0.023B 7.13
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.022B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
Lipocine (LPCN) United States $0.022B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.021B 0.00
India Globalization Capital (IGC) United States $0.018B 0.00
Bio-Path Holdings (BPTH) United States $0.017B 0.00
Novan (NOVN) United States $0.016B 0.00
Can-Fite Biopharma (CANF) Israel $0.013B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
Shineco (TYHT) China $0.012B 0.00
KemPharm (KMPH) United States $0.011B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Vical (BBI) United States $0.010B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.006B 0.00
HANCOCK JAFFE (HJLI) United States $0.005B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Flex Pharma (SLRX) United States $0.003B 0.00